CD8A and colorectal cancer: Similarly, combining anti-MS4A4A antibodies with PD1 blockade improves immune checkpoint inhibition by preventing macrophage M2 polarization and enhancing CD8+ T cell infiltration in advanced colorectal cancer (190).